FDA Adverse Event Injury Summary report: N

SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM

MDR report key: 22964001 · Received September 4, 2025

Report

Report Number
3005875675-2025-00067
Event Type
Injury
Date Received
September 4, 2025
Date of Event
November 7, 2024
Report Date
September 4, 2025
Manufacturer
GYNESONICS
Product Code
KNF
UDI-DI
10817929020333
PMA / PMN Number
K240503
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WAS NO REPORT OF DEVICE MALFUNCTION DURING THE PROCEDURE AND THE SYSTEM FUNCTIONED AS EXPECTED. SUBMISSION OF THIS REPORT IS ASSOCIATED WITH THE RECENT ACQUISITION OF GYNESONICS BY HOLOGIC, INC. DURING THE INTEGRATION INTO HOLOGIC'S ADVERSE EVENT REPORTING SYSTEM AND PROCEDURES, A REVIEW OF HISTORICAL ADVERSE EVENTS WAS PERFORMED. AS A RESULT THIS EVENT WAS IDENTIFIED AS BEING REPORTABLE ON AUG 12, 2025 AND IS BEING REPORTED RETROACTIVELY OUT OF AN ABUNDANCE OF CAUTION.

Description of Event or Problem · 0

ON (B)(6) 2024 IT WAS INITIALLY REPORTED TO GYNESONICS THAT A PATIENT TREATED WITH THE SONATA SYSTEM WAS HOSPITALIZED/ ADMITTED LONGER. PATIENT RECEIVED SONATA FOR A TYPE 1 FIBROID. PATIENT FELT WELL AFTER TREATMENT AND WAS DISCHARGED. AFTER 2-3 WEEKS SHE CAME IN FOR EXAMINATION WITH ABDOMINAL PAIN. SHE RECEIVED HYSTEROSCOPIC SURGERY BECAUSE THERE WERE FIBROID REMAINS IN THE CAVITY CAUSING PROBLEMS. PATIENT WAS REPORTED TO BE DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1876475 SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM KNF GYNESONICS SONATA2-220 10817929020333

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention| H